RACHEL PHILLIPS: Open Payments
NPI 1609395946 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,760 in 85 payments from 21 companies in 2025. Trend: 2023 $1,332 · 2024 $948 · 2025 $2,760
Food & beverage: $1,763Travel & lodging: $997
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 9 | $1,320 |
| GlaxoSmithKline, LLC. | 11 | $174 |
| GENZYME CORPORATION | 8 | $168 |
| AstraZeneca Pharmaceuticals LP | 8 | $151 |
| Grifols USA, LLC | 7 | $137 |
| Actelion Pharmaceuticals US, Inc. | 7 | $132 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $88 |
| Merck Sharp & Dohme LLC | 4 | $85 |
| Viatris Specialty LLC | 5 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
Products named: INSPIRE, DUPIXENT, NUCALA, Prolastin-C Liquid, OPSUMIT, GLASSIA, WINREVAIR, TEZSPIRE.
Industry payments across GA — which companies pay providers there.
